Tracking Supply Problems for Heart Ultrasound Catheters Used in Heart Procedures
Observes how supply problems affect access to intracardiac echocardiography catheters in heart care.
Plain-language title generated from the registry record
Registry title: Intracardiac Echocardiography Catheter Supply-Chain Reliability and Clinical Access Study
Key facts
- Where
- New York, United StatesSee the site
Where in United States
- Truway Health, Inc.New York, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Truway Health, Inc.
- Trial code
- NCT07788040
- Record updated
- 26 October 2026
- Original description
The ICE-ACCESS study is a prospective observational study designed to evaluate how procurement reliability, distribution restrictions, supply-chain interruptions, and device availability affect access to intracardiac echocardiography (ICE) catheters and related clinical care. The study will document real-world procurement attempts, fulfillment outcomes, order delays, cancellations, product substitutions, distributor restrictions, acquisition timelines, and other supply-access events involving ICE catheter devices.Read full original descriptionShow less
Prospective Observational Evaluation of Procurement Reliability, Distribution Restrictions, Supply-Chain Disruptions, and Clinical Access to Intracardiac Echocardiography Catheters
The ICE-ACCESS study is a prospective observational study designed to evaluate how procurement reliability, distribution restrictions, supply-chain interruptions, and device availability affect access to intracardiac echocardiography (ICE) catheters and related clinical care. The study will document real-world procurement attempts, fulfillment outcomes, order delays, cancellations, product substitutions, distributor restrictions, acquisition timelines, and other supply-access events involving ICE catheter devices.
Where participant-level clinical data are available under the approved protocol, the study will also examine whether device-access problems are associated with procedure delays, rescheduling, changes in planned device use, alternative sourcing, increased administrative burden, or other measurable effects on care delivery.
The study does not assign participants to a device or treatment and does not alter clinical decision-making. Procurement and clinical events are observed as they occur in routine practice. The study is intended to develop a structured evidence base for understanding the reliability of the medical-device supply chain and the potential relationship between procurement disruption and timely access to cardiovascular procedures.
Inclusion: Age 18 years or older; Participant is scheduled for, referred for, or undergoing an electrophysiology, cardiac ablation, structural heart, or other cardiovascular procedure for which intracardiac echocardiography or an ICE catheter is clinically planned, requested, considered, or utilized; A documented ICE-catheter procurement or device-access episode can be identified and evaluated under the study protocol; Sufficient procurement, scheduling, clinical, or administrative information is available to determine device-access timing and study outcomes; Participant falls within either the documented ICE catheter access-disruption cohort or the timely-access comparison cohort; Able to provide informed consent when prospective consent is required by the applicable IRB determination, or eligible for inclusion under an IRB-approved waiver or alteration of consent where applicable.
Exclusion: Younger than 18 years of age; No planned, requested, or clinically relevant intracardiac echocardiography catheter involvement in the associated cardiovascular procedure; Procurement or clinical records are insufficient to establish the timing or final disposition of the device-access episode; Device access occurred outside the predefined study observation period; Procedure delay or cancellation is clearly attributable solely to an unrelated clinical or administrative circumstance and no qualifying ICE catheter access event occurred; Participation would conflict with another protocol, institutional restriction, or applicable human-subject protection requirement; Individuals for whom required authorization, consent, or permitted IRB-approved waiver criteria are not satisfied.